Veterinary vaccines market to Perceive Substantial Growth during 2028
According to our new research
study on “Veterinary
Vaccines Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by
Vaccine Type and Technology,” the market is projected to reach US$ 15,536.38
million in 2028 from US$ 9,984.65 million in 2021; it is estimated to register
a CAGR of 6.5% from 2021 to 2028.
The global veterinary vaccines
market, based on vaccine type, is segmented into livestock vaccines, companion
animal vaccines, and others. The livestock vaccines segment is likely to hold
the largest market share in 2021. However, the companion animal segment is
anticipated to register the highest CAGR of 7.0% during the forecast period.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003539/
The report highlights trends
existing in the market, and drivers and hindrances pertaining to the market
growth. The companion animal category is predicted to increase at the highest
rate because of the high frequency with which these animals come into contact
with people and the fact that illnesses such as rabies can harm humans as well.
Additionally, a boost in the adoption of these companion animals and increased
knowledge of the need for dog and cat vaccinations contribute to the market's
growth. Cats and dogs receive companion animal immunizations. Vaccines for
livestock are frequently administered to farm animals. In 2020, the livestock
vaccination market held the largest market share. The reason for this is that
these animals are routinely vaccinated more frequently than companion animals.
Besides, the segment's quick rise has been attributed to the rapid expansion of
companion animal vaccinations, advancements in diagnostic services and vaccine
technology, and worries over vaccine safety. Additionally, the industry is
benefited by improving immunization regimens in response to changing disease
patterns and the pet population. Thus, the benefits of veterinary vaccines are
expected to drive the segment during the forecast period.
Boehringer Ingelheim International
GmbH; Zoetis Inc.; Merck & Co., Inc.; Virbac; BIOVAC; NEOGEN Corporation;
Elanco; HIPRA; Ceva; and Hester Biosciences Limited are a few leading companies
operating in the veterinary vaccines market. The companies adopt inorganic and
organic growth strategies to expand their footprints and product portfolio
worldwide to meet the rising demands for veterinary vaccines. In July 2021,
Boehringer Ingelheim launched FreVAX smartphone app (2.0 version) for the
management of FreVAX intramuscular needle-free device.
Get Report
Sample - https://www.theinsightpartners.com/reports/veterinary-vaccines-market
About Us:
The Insight Partners is a one stop industry research provider of
actionable intelligence. We help our clients in getting solutions to their
research requirements through our syndicated and consulting research services.
We specialize in industries such as Semiconductor and Electronics, Aerospace
and Defense, Automotive and Transportation, Biotechnology, Healthcare IT,
Manufacturing and Construction, Medical Device, Technology, Media and
Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like
further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1–646–491–9876
Comments
Post a Comment